Expanding the Donor Pool in Heart Transplantation: Current Strategies and Future Perspectives

Unless otherwise noted, speakers have nothing to disclose.

Moderators

Yasir Abu-Omar, MD PhD FRCS
Ezequiel Molina, MD

Presentations

  1. Donation after circulatory death does not worsen survival after heart transplant for patients with mechanical circulatory support
    Erin M. Schumer, MD, MPH
     
  2. Developments in Transplantation: DCD, Machine-based Perfusion, Xenotransplantation, and UNOS Allocation System Changes
    David D'Alessandro, MD
    Disclosure: Abiomed Inc.: Consultant (Ongoing), Speaker (Ongoing); Paragonix: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)
     
  3. Longer Time Between Hospital Admission and Brain Death Declaration Correlates to Favorable Donor Characteristics but Decreased Acceptance: A Missed Opportunity?
    Jason Greenberg, MD
     
  4. The Use of Donor Hearts 50 Years or Older to Septuagenarians in Heart Transplant: The Potential of Expanding the Donor Pool in Older Patients and Increasing the Availability of Younger Hearts
    Suguru Ohira, MD, PhD
     
  5. Does Aggressive Utilization of Marginal Donor Organs at High-Volume Centers Affect Center-Level Heart Transplant Outcomes?
    Syed Shahyan Bakhtiyar, MD, MBE
     
  6. Expert Commentary / Pushing the Edge on Donor Selection
    Victor Pretorius, MBchB
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Activity opens: 
02/01/2023
Activity expires: 
02/01/2026
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Unless otherwise noted, speakers have nothing to disclose.

Moderators

Yasir Abu-Omar, MD PhD FRCS
Ezequiel Molina, MD

Presentations

  1. Donation after circulatory death does not worsen survival after heart transplant for patients with mechanical circulatory support
    Erin M. Schumer, MD, MPH
     
  2. Developments in Transplantation: DCD, Machine-based Perfusion, Xenotransplantation, and UNOS Allocation System Changes
    David D'Alessandro, MD
    Disclosure: Abiomed Inc.: Consultant (Ongoing), Speaker (Ongoing); Paragonix: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)
     
  3. Longer Time Between Hospital Admission and Brain Death Declaration Correlates to Favorable Donor Characteristics but Decreased Acceptance: A Missed Opportunity?
    Jason Greenberg, MD
     
  4. The Use of Donor Hearts 50 Years or Older to Septuagenarians in Heart Transplant: The Potential of Expanding the Donor Pool in Older Patients and Increasing the Availability of Younger Hearts
    Suguru Ohira, MD, PhD
     
  5. Does Aggressive Utilization of Marginal Donor Organs at High-Volume Centers Affect Center-Level Heart Transplant Outcomes?
    Syed Shahyan Bakhtiyar, MD, MBE
     
  6. Expert Commentary / Pushing the Edge on Donor Selection
    Victor Pretorius, MBchB